Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) is struggling to gain traction with investors, as evidenced by its 0.29 million shares volume. The daily trading volume average remained 0.19 million shares over the course of 3 months. The stock had opened the regular trading at $2.25 and managed a -4.55% price change to reach $2.1 through the close.Titan Pharmaceuticals, Inc. (TTNP) Analyst Opinion
Titan Pharmaceuticals, Inc. has a consensus outperform rating from 1 Wall Street analysts, and the number of shares currently sold short amount to at least 5.06% of shares outstanding. The stock spiked 20% last month and is down -47.5 this year. Wall Street is only getting more bullish on the stock, with 1 of analysts who cover TTNP having a buy-equivalent rating. Analysts have placed a $6 price target on Titan Pharmaceuticals, Inc., suggesting a 185.71% gain from recent close. It’s currently trading about -56.25% below its 52-week high.
Titan Pharmaceuticals, Inc. (TTNP) failed to surprise the stock market in its last reported earnings when it earned -$0.17 a piece versus the consensus-estimated -$0.15. Its revenue totaled $100000 up 150% from the previous quarter.Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) Intraday View
This stock (TTNP) is ahead of its 52-week low with 61.54%. Its last month’s stock price volatility remained 18.18% which for the week stands at 13.43%. The share price has moved forward from its 20 days moving average, trading at a distance of 1.51% and stays 18.11% away from its 50 days moving average. Over the last five days, shares have managed 5% gains and now is down -19.13% since hitting its 200-day moving average of $2.49. Titan Pharmaceuticals, Inc. (TTNP) has made its way to a 12-month decline of -53.95%.
Turning to Roku, Inc. (NASDAQ:ROKU), its shares were trading at $19.5 a gain of $0.71, on the trading floor. The stock, after opening at $18.72, touched a high of $20.1495 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2.5. Roku, Inc. has 1 buy ratings, 4 holds and 0 sells even after the stock tumbled -34.56% from its high of $ 29.80 to a $1.87 billion market value through last close.
The company’s consensus rating on Reuter’s scale improved from 0 to 2.5 during a month. Analysts set a 12-month price target of $25 a share. The target implies a 28.21% spike from where the shares are currently trading. Also, the current price highlights a discount of 43.59% to analysts’ high consensus price target.Roku, Inc. (NASDAQ:ROKU) Intraday Trading
The counter witnessed a trading volume of 2.11 million shares versus an average volume of 8.33 million shares during last trading session. Its last month’s stock price volatility remained 6.48% which for the week approaches 6.67%. The lowest price the stock reached in the last trading day was $18.7001 and compares with the $15.75 52-week low. The stock recovered 23.81% since its low point and has performed -17.02% year-to-date.